Delix Therapeutics jobs and careers
Boston, MA, United States
About Delix Therapeutics
Delix Therapeutics is applying modern tools of pharmaceutical development to some of nature's most ancient therapies, psychedelics. Through its discovery platform, Delix has identified a new class of non-hallucinogenic versions of psychedelic compounds with favorable safety and therapeutic profiles. Delix is rapidly advancing these psychoplastogen compounds through preclinical and clinical development, with the goal of one day alleviating mental suffering through its FDA-approved, take-home medicines.
Founded in 2019 by David E. Olson and Nick Haft.
- Founded
- 2019
- Employees
- 1 to 10
- Total funding
- $119.1M
- Headquarters
- Boston
Leadership
The top of Delix Therapeutics's org chart, with how many people report into each leader.
Mark Rus
CEO
12 reports
Eliseo Salinas
Head of Research And Development
5 reports
David Olson
Chief Innovation Officer and Head of the Scientific Advisory Board
2 reports
Retsina Meyer
Head of Corporate Strategy
Matt Gorman
CFO
Tricia Mccall
Chief People Officer (CPO)
Board
Nick Haft
Director
John Krystal
Advisor
Florence Wagner
Advisor
Craig Lindsley
Advisor
Conor Liston
Advisor
Jacob Hooker
Advisor
Jobs at Delix Therapeutics
No open positions right now. Explore more companies on TheJobsMap.